🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of acetaminophen, alleging the firms concealed safety concerns that the drug created to pediatric brain development.

The lawsuit arrives thirty days after President Donald Trump publicized an unsubstantiated connection between using acetaminophen - also known as paracetamol - during pregnancy and autism spectrum disorder in children.

Paxton is taking legal action against J&J, which previously sold the medication, the only pain reliever approved for women during pregnancy, and the current manufacturer, which currently produces it.

In a official comment, he claimed they "misled consumers by profiting off of suffering and pushing pills regardless of the potential hazards."

The manufacturer says there is no credible evidence connecting acetaminophen to autism spectrum disorder.

"These manufacturers misled for generations, intentionally threatening numerous people to increase profits," Paxton, a Republican, declared.

Kenvue stated officially that it was "very worried by the spread of false claims on the reliability of paracetamol and the possible consequences that could have on the well-being of US mothers and children."

On its website, Kenvue also mentioned it had "continuously evaluated the relevant science and there is no credible data that indicates a proven link between taking acetaminophen and autism spectrum disorder."

Associations representing physicians and healthcare providers concur.

The American College of Obstetricians and Gynecologists has declared paracetamol - the primary component in acetaminophen - is one of the few options for women during pregnancy to address pain and fever, which can create significant medical dangers if ignored.

"In multiple decades of studies on the use of acetaminophen in gestation, no reliable research has successfully concluded that the use of acetaminophen in any trimester of gestation leads to brain development issues in children," the association said.

This legal action mentions latest statements from the Trump administration in claiming the medication is reportedly hazardous.

In recent weeks, Trump caused concern from health experts when he advised women during pregnancy to "struggle intensely" not to take Tylenol when sick.

Federal regulators then published an announcement that doctors should think about restricting the consumption of Tylenol, while also stating that "a causal relationship" between the drug and autism spectrum disorder in minors has not been established.

The Health Department head Robert F Kennedy Jr, who manages the FDA, had promised in April to conduct "extensive scientific investigation" that would determine the cause of autism spectrum disorder in a matter of months.

But authorities warned that discovering a sole reason of autism spectrum disorder - believed by scientists to be the consequence of a intricate combination of genetic and external influences - would be difficult.

Autism is a category of enduring cognitive variation and condition that influences how people encounter and engage with the world, and is diagnosed using physician assessments.

In his court filing, the attorney general - aligned with the former president who is seeking federal office - asserts the manufacturer and Johnson & Johnson "deliberately disregarded and sought to suppress the evidence" around paracetamol and autism.

The case attempts to require the companies "destroy any promotional materials" that asserts acetaminophen is secure for expectant mothers.

The Texas lawsuit parallels the complaints of a collection of parents of young ones with autism and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in recently.

The court dismissed the legal action, saying investigations from the plaintiffs' authorities was not conclusive.